Activities of enzymes that hydrolyze adenine nucleotides in platelets from patients with rheumatoid arthritis

Clinical Biochemistry

Volumn 43, Issue 13-14, 2010, Pages 1096-1100

  Becker, Lara V ^a   Rosa, Cintia S ^a   Souza, Viviane do C G ^a   Bagatini, Margarete D ^a   Casali, Emerson A ^b   Leal, Claudio Alberto M ^a   da Silva, João Carlos N ^a   Moretto, Maria Beatriz ^a   Pinheiro, Francielle de V ^a   Morsch, Vera Maria ^a   Schetinger, Maria Rosa C ^a   Leal, Daniela B R ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b CENTRO UNIVERSITÁRIO METODISTA IPA   (Brazil)

Author keywords

Adenine nucleotides; Adenosine; Atherosclerosis; Platelets; Rheumatoid arthritis

Indexed keywords

ADENINE NUCLEOTIDE; ADENOSINE; ADENOSINE DEAMINASE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; ECTO 5' NUCLEOTIDASE; ECTO ADENOSINE DEAMINASE; ECTO NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE; ECTO NUCLEOTIDE PYROPHOSPHATASE; HYDROLASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; ENZYME SUBSTRATE; FEMALE; HUMAN; HYDROLYSIS; INFLAMMATION; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; THROMBOCYTE; THROMBOCYTE AGGREGATION;

5'-NUCLEOTIDASE; ADENINE NUCLEOTIDES; ADENOSINE DEAMINASE; ADULT; ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; BLOOD PLATELETS; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYDROLASES; HYDROLYSIS; MALE; MIDDLE AGED; PHOSPHORIC DIESTER HYDROLASES; PYROPHOSPHATASES;

EID: 77956175931     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.06.011     Document Type: Article

References (36)

1. Kamanli A., Naziroglu M., Aydilek N., et al. Plasma lipid peroxidation and antioxidant levels in patients with rheumatoid arthritis. Cell Biochem Funct 2004, 22:53-57.
2. Myllykangas-Luosujarvi R., Aho K., Kautiainen H., et al. Cardiovascular mortality in women with rheumatoid arthritis. J Rheumatol 1995, 22:1065-1067.
3. Kullo I., Gau G., Tajik A. Novel risk factors for atherosclerosis. Mayo Clin Proc 2000, 75:369-380.
4. Vitta J.A., Keaney J.F. Endothelial function: a barometer for cardiovascular risk?. Circulation 2002, 106:640-642.
5. Leon C., Hechler B., Vial C., et al. The P2Y1 receptor is an ADP receptor antagonist by ATP and expressed in platelets and megakaryoblasti cells. FEBS Lett 1997, 403:26-30.
6. Marcus A.J., Broekman M.J., Drosopoulos J.H., et al. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Invest 1997, 996:1351-1360.
7. Birk A.V., Broekman J., Gladek E.M., et al. Role of extracellular ATP metabolism in regulation of platelet reactivity. J Lab Clin Med 2002, 140:166-175.
8. Park H.S., Hourani S.M. Differential effects of adenine nucleotide analogues on shape change and aggregation induced by adenosine 5-diphosphate (ADP) in human platelet. Br J Pharmacol 1999, 127:1359-1366.
9. Fürstenau C.R., Trentin D.S., Barreto-Chaves M.L.M., et al. Ecto-nucleotide pyrophosphatase/phosphodiesterase as part of a multiple system for nucleotide hydrolysis by platelets from rats: kinetic characterization and biochemical properties. Platelets 2006, 17:84-91.
10. Pearson J.D., Carleton J.S., Gordon J.L. Metabolism of adenine nucleotides by ectoenzymes of vascular endothelial and smooth-muscle cells in culture. Biochem J 1980, 190:421-429.
11. Bigonnesse F., Lévesque S.A., Kukulski F., et al. Cloning and characterization of mouse nucleoside triphosphate diphosphohydrolase-8. Biochemistry 2004, 43:5511-5519.
12. Colgan S.P., Eltzschig H.K., Eckle T., et al. Physiological roles for ecto-5'-nucleotidase (CD73). Purinergic Signal 2006, 2:351-360.
13. Franco R., Casado V., Ciruela F., et al. Cell surface adenosine deaminase: much more than an ectoenzyme. Prog Neurobiol 1997, 52:283-294.
14. Yegutkin G.G. Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signaling cascade. Biochim Biophys Acta (BBA) Molecular Cell Res 2008, 1783:673-694.
15. Goodson N., Marks J., Lunt M., et al. Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s. Ann Rheum Dis 2005, 64:1595-1601.
16. Gawaz M. Platelets in the onset of atherosclerosis. Blood Cells Mol Dis 2006, 36:206-210.
17. Arnett F.C., Edworthy S.M., Bloch D.A., et al. The American Rheumatism Association 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
18. Pilla C., Emanuelli T., Frassetto S.S., et al. ATP diphosphohydrolase activity (apyrase, E.C. 3.6.1.5) in human blood platelets. Platelets 2006, 7:225-230.
19. Lunkes G.I., Lunkes D., Stefanello F., et al. Enzymes that hydrolyze adenine nucleotides in diabetes and associated pathologies. Thromb Res 2003, 109:189-194.
20. Chan K., Delfert D., Junger K.D. A direct colorimetric assay for Ca 2+- ATPase activity. Anal Biochem 1986, 157:375-378.
21. Guisti G., Galanti B. Colorimetric Method. Methods of enzymatic analysis 1984, 315-323. Weinheim, Verlag Chemie. H.U. Bergmeyer (Ed.).
22. Born G.V.R., Cross M.J. The aggregation of blood platelets. J Physiol 1963, 95:168-178.
23. Voelter W., Zech K., Arnold P., et al. Determination of selected pyrimidines, purines and their metabolites in serum and urine by reversed-phase ion-pair chromatography. J Chromatogr 1980, 199:345-354.
24. Bradford M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
25. Pasceri V., Yeh E.T. A tale of two diseases: atherosclerosis and rheumatoid arthritis. Circulation 1999, 100:2124-2126.
26. McInnes I.B. Rheumatoid arthritis: from bench to bedside. Rheum Dis Clin N Am 2001, 27:373-387.
27. Joseph J.E., Harrison P., Mackie I.J., et al. Increased circulating platelet-leukocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. Br J Haematol 2001, 115:451-459.
28. Massberg S., Brand K., Gruner S., et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 2002, 196:887-896.
29. Fredholm B.B., Abbracchio M.P., Burnstock G., et al. Nomenclature and classification of purinoreceptors. Pharmacol Rev 1994, 46:143-152.
30. Merighi S., Mirandola P., Varani K., et al. A glance at adenosine receptors: novel target for antitumor therapy. Pharmacol Ther 2003, 100:31-48.
31. Ryan L.M., Rachow J.W., McCarty Synovial fluid ATP: a potential substrate for the production of inorganic pyrophosphate. J Rheumatol 1991, 18:716-720.
32. Frassetto S.S., Rd Dias, Sarkis J.J.F. Characterization of an ATP diphosphohydrolase activity (EC 3615) in rat blood platelets. Mol Cell Biochem 1993, 1:47-55.
33. Maldonado P.A., Corrêa M.C., Becker L.V., et al. Ectonucleotide pyrophosphatase/phosphodiesterase (E-NPP) and adenosine deaminase (ADA) activities in patients with uterine cervix neoplasia. Clin Biochem 2008, 41:400-406.
34. Bagatini M.D., Martins C.C., Battisti V., et al. Hydrolysis of adenine nucleotides in platelets from patients with acute myocardial infarction. Clin Biochem 2008, 41:1181-1185.
35. Schmatz R., Schetinger M.R.C., Spanevello R.M., et al. Effects of resveratrol on nucleotide degrading enzymes in streptozotocin-induced diabetic rats. Life Sci 2009, 84:345-350.
36. Nakamachi Y., Koshiba M., Nakazawa T., et al. Specific increase in enzymatic activity of adenosine deaminase 1 in rheumatoid synovial fibroblasts. Arthritis Rheum 2003, 48:668-674.